Medicine and Dentistry
Neurofibromatosis Type I
92%
Neoplasm
79%
Plexiform Neurofibroma
64%
Schwannomatosis
38%
Clinical Trial
34%
Neurofibromatosis Type II
32%
Ganglioglioma
29%
Neurofibromatosis
26%
Malignant Peripheral Nerve Sheath Tumor
19%
Nerve Sheath Tumor
18%
Peripheral Nerve
14%
Magnetic Resonance Imaging
14%
Neuro-Oncology
14%
Brain Tumor
14%
Disease
13%
Glioblastoma
13%
Vestibular Schwannoma
12%
Neurinoma
11%
Biological Marker
11%
Carboxamide
10%
Proton Transport
10%
Meningioma
9%
Patient-Reported Outcome
9%
Quality of Life
9%
Surgery
8%
Temozolomide
8%
Diagnosis
7%
Malignant Neoplasm
7%
Magnetic Resonance Imaging
7%
Genetic Disorder
7%
Clinician
6%
Symptom
6%
Selumetinib
6%
Breast Cancer
5%
Schwann Cell
5%
Drug Megadose
5%
Rare Disease
5%
Pediatrics
5%
Radiation Therapy
5%
Keyphrases
Neurofibromatosis Type 1 (NF-1)
100%
Neurofibromatosis Type I
72%
Neurofibromatosis Type 2
29%
Cutaneous Neurofibroma
27%
Schwannomatosis
26%
Tumor
26%
Plexiform Neurofibroma
23%
Glioma
16%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
16%
Clinical Trials
15%
Neurofibromatosis
14%
Peripheral Nerve Sheath Tumor
12%
Vestibular Schwannoma
11%
Neoplasms
9%
High-grade Glioma
8%
Consensus Recommendations
8%
Amide Proton Transfer-weighted Imaging
8%
Temozolomide
8%
Schwannoma
7%
Oligodendroglial Tumors
7%
Astrocytic Tumor
7%
Newly Diagnosed
6%
Isocitrate Dehydrogenase 1 (IDH1)
6%
Radiation Therapy
6%
Meningioma
6%
Type I Neurofibromatosis
6%
Magnetic Resonance Imaging
5%
Selumetinib
5%
Bevacizumab
5%
NF-2
5%
Response Assessment in Neuro-Oncology Criteria
5%
Genomic Landscape
5%
Glioblastoma
5%
Brain Tumor
5%
Neurofibroma
5%
Clinical Features
5%
